News on Medial

Related News

CureBay acquires Saveo’s pharma distribution business

EntrackrEntrackr · 22h ago
CureBay acquires Saveo’s pharma distribution business
Medial

CureBay acquires Saveo’s pharma distribution business CureBay, a hybrid healthcare platform, has acquired the pharma distribution business of Saveo Healthtech for an undisclosed amount. The deal includes Saveo’s network serving over 10,000 retail pharmacies across southern India, along with distribution hubs in Bengaluru and Hyderabad, procurement capabilities, and a tech-enabled ordering platform. CureBay plans to integrate Saveo’s distribution infrastructure with its existing healthcare network to improve fulfillment cycles and inventory visibility. Founded by Priyadarshi Mohapatra, CureBay operates a network of over 190 eClinics across 15,000 villages and has served more than one million patients. The company provides teleconsultation, diagnostics, pharmacy access, and referral services through a hybrid model combining physical centres and digital tools. Saveo’s founders Vivek Jaiswal and Shivansh Shrivastava continue to focus on building the company’s brand-led vertical independently under the parent company funded by existing investors. Saveo previously operated two segments, distribution and branded pharma, with the distribution business now divested. The founders are scaling Silvercross, a direct-to-retail pharma brand operating across 18 states, with an ARR of Rs 100 crore and EBITDA of -3%. The brand also provides first-of-its-kind, batch-level lab reports accessible via QR codes on medicine packaging. With this acquisition, CureBay is moving towards a full-stack healthcare model by integrating medicine distribution into its core offering. The company has already completed most of the integration and is deploying combined operations in select markets. Back in May last year, CureBay had raised $21 million in its Series B funding round, led by Bertelsmann India Investments at around $75 million valuation.

Download the medial app to read full posts, comements and news.